Okano, N., Mizutani, T., Nagashima, F., & Furuse, J. (2021). Stereotactic body radiotherapy plus pembrolizumab and trametinib for pancreatic cancer. The Lancet Oncology, 22(10), e423. https://doi.org/10.1016/S1470-2045(21)00489-7
Citácia podle Chicago (17th ed.)Okano, Naohiro, Tomonori Mizutani, Fumio Nagashima, a Junji Furuse. "Stereotactic Body Radiotherapy Plus Pembrolizumab and Trametinib for Pancreatic Cancer." The Lancet Oncology 22, no. 10 (2021): e423. https://doi.org/10.1016/S1470-2045(21)00489-7.
Citácia podľa MLA (8th ed.)Okano, Naohiro, et al. "Stereotactic Body Radiotherapy Plus Pembrolizumab and Trametinib for Pancreatic Cancer." The Lancet Oncology, vol. 22, no. 10, 2021, p. e423, https://doi.org/10.1016/S1470-2045(21)00489-7.
Upozornenie: Tieto citáce sú generované automaticky. Nemusia byť úplne správne podľa citačných pravidiel..